Added to YB: 2026-09-22
Pitch date: 2026-09-18
EOLS [bullish]
Evolus, Inc.
+0.76%
current return
Author Info
Emerging Moats is a newsletter that will produce a stock research report every four weeks, provide regular updates on existing stocks in the Emerging Moats universe, and regularly update my portfolio transactions and returns. Sign up for the newsletter.
Company Info
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
Market Cap
$519.2M
Pitch Price
$7.93
Price Target
N/A
Dividend
N/A
EV/EBITDA
-64.45
P/E
-14.92
EV/Sales
2.02
Sector
Pharmaceuticals
Category
growth
Evolus: Aesthetic Spending Bounceback (Ticker: EOLS)
EOLS (earnings): Evolus’s recent results support the view that U.S. aesthetic-injectable spending is beginning to recover: revenue growth accelerated to 21% last quarter, confirming the growth trajectory, while operating leverage and progress toward GAAP profitability are emerging. Multiple company-specific and sector-wide growth levers remain through 2030, though cost discipline is still the key concern after the shares more than doubled from March lows.
Read full article (2 min)